Research profile
AOD-9604
AOD-9604 is a modified fragment of human growth hormone that was studied for effects on fat metabolism and body weight.
- Human obesity trial reviewed
- Evaluation only
Amnavero
AOD-9604
What the research found
In a 24-week oral obesity trial summarized by FDA, weight loss with AOD-9604 did not differ significantly from placebo.
What remains uncertain
The reviewed trial did not establish a weight-loss benefit. Evidence on other formulations and long-term safety remains limited.